Patents by Inventor Olivier Dalmas

Olivier Dalmas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12276656
    Abstract: Disclosed herein are antigenic peptide-MHC complexes, termed comPACT polypeptides and comPACT polynucleotides, and methods of producing such complexes. Also discloses herein are methods of producing libraries of comPACT polynucleotides and polypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells with high accuracy. Dual particle detection approaches for detection of neoantigen specific T cells with improved sensitivity and specificity are provided. Signal to noise ratio analysis of isolated T cells for detection of neoantigen-specific T cells with improved T cells is also provided.
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: April 15, 2025
    Assignee: ADOC SSF, LLC
    Inventors: Songming Peng, Boi Bryant Quach, Duo An, Xiaoyan Robert Bao, Alex Franzusoff, Barbara Sennino, Olivier Dalmas, Stefanie Mandl-Cashman
  • Patent number: 12240885
    Abstract: Disclosed herein are antigenic peptide-MHC molecules, termed comPACTs, and methods of producing such molecules. Also disclosed herein are methods of producing libraries of comPACT polynucleotides and polypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: March 4, 2025
    Assignee: ADOC SSF, LLC
    Inventors: Olivier Dalmas, Zheng Pan, Michael Bethune, Songming Peng
  • Publication number: 20240271121
    Abstract: Disclosed herein are antigenic peptide-MHC molecules, termed comPACT2.0 polypeptides, and methods of producing such molecules. Also disclosed herein are methods of producing libraries of comPACT2.0 polynucleotides and polypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells.
    Type: Application
    Filed: April 12, 2024
    Publication date: August 15, 2024
    Applicant: ADOC SSF, LLC
    Inventors: Olivier Dalmas, Jonathan B. Johnston, Elizabeth Speltz
  • Publication number: 20230194504
    Abstract: Disclosed herein are antigenic peptide-MHC complexes, termed comPACT polypeptides and comPACT polynucleotides, and methods of producing such complexes. Also discloses herein are methods of producing libraries of comPACT polynucleotides and polypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells with high accuracy. Dual particle detection approaches for detection of neoantigen specific T cells with improved sensitivity and specificity are provided. Signal to noise ratio analysis of isolated T cells for detection of neoantigen-specific T cells with improved T cells is also provided.
    Type: Application
    Filed: October 28, 2022
    Publication date: June 22, 2023
    Applicant: PACT PHARMA, INC.
    Inventors: Songming Peng, Boi Bryant Quach, Duo An, Xiaoyan Robert Bao, Alex Franzusoff, Barbara Sennino, Olivier Dalmas, Stefanie Mandl-Cashman
  • Patent number: 11513113
    Abstract: Disclosed herein are antigenic peptide-MHC complexes, termed comPACT polypeptides and comPACT polynucleotides, and methods of producing such complexes. Also discloses herein are methods of producing libraries of comPACT polynucleotides and polypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells with high accuracy. Dual particle detection approaches for detection of neoantigen specific T cells with improved sensitivity and specificity are provided. Signal to noise ratio analysis of isolated T cells for detection of neoantigen-specific T cells with improved T cells is also provided.
    Type: Grant
    Filed: February 12, 2020
    Date of Patent: November 29, 2022
    Assignee: PACT PHARMA, INC.
    Inventors: Songming Peng, Boi Bryant Quach, Duo An, Xiaoyan Robert Bao, Alex Franzusoff, Barbara Sennino, Olivier Dalmas, Stefanie Mandl-Cashman
  • Publication number: 20210070834
    Abstract: Disclosed herein are antigenic peptide-MHC molecules, termed comPACTs, and methods of producing such molecules. Also disclosed herein are methods of producing libraries of comPACT polynucleotides and polypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Applicant: PACT PHARMA, INC.
    Inventors: Olivier Dalmas, Zheng Pan, Michael Bethune, Songming Peng
  • Patent number: 10875905
    Abstract: Disclosed herein are antigenic peptide-MHC molecules, termed comPACTs, and methods of producing such molecules. Also disclosed herein are methods of producing libraries of comPACT polynucleotides and polypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: December 29, 2020
    Assignee: PACT PHARMA, INC.
    Inventors: Olivier Dalmas, Zheng Pan, Michael Bethune, Songming Peng
  • Publication number: 20200256849
    Abstract: Disclosed herein are antigenic peptide-MHC complexes, termed comPACT polypeptides and comPACT polynucleotides, and methods of producing such complexes. Also discloses herein are methods of producing libraries of comPACT polynucleotides and polypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells with high accuracy. Dual particle detection approaches for detection of neoantigen specific T cells with improved sensitivity and specificity are provided. Signal to noise ratio analysis of isolated T cells for detection of neoantigen-specific T cells with improved T cells is also provided.
    Type: Application
    Filed: February 12, 2020
    Publication date: August 13, 2020
    Applicant: PACT Pharma, Inc.
    Inventors: Songming Peng, Boi Bryant Quach, Duo An, Xiaoyan Robert Bao, Alexis Franzusoff, Barbara Sennino, Olivier Dalmas, Stefanie Mandl-Cashman
  • Publication number: 20200062819
    Abstract: Disclosed herein are antigenic peptide-MHC molecules, termed comPACTs, and methods of producing such molecules. Also disclosed herein are methods of producing libraries of comPACT polynucleotides and polypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells.
    Type: Application
    Filed: November 8, 2019
    Publication date: February 27, 2020
    Applicant: PACT PHARMA, INC.
    Inventors: Olivier Dalmas, Zheng Pan, Michael Bethune, Songming Peng